{"0.72":{"start":"0.719","dur":"1.44","text":"Maryellen Giger:\nGood morning."},"2.16":{"start":"2.159","dur":"2.921","text":"I am a medical physicist imaging scientist."},"5.08":{"start":"5.08","dur":"8.4","text":"I work in extracting information from images\nand my -- the mouse -- my collaborator, Yuan"},"13.48":{"start":"13.48","dur":"4.849","text":"Ji, is a biostatistician working in the field\nof genomics."},"18.33":{"start":"18.329","dur":"6.551","text":"We\u2019re working with the TCGA Breast Phenotype\nResearch Group on extracting information from"},"24.88":{"start":"24.88","dur":"1.409","text":"the MR images."},"26.29":{"start":"26.289","dur":"6.731","text":"Unfortunately, Yuan Ji came down ill today;\nhowever, Yitan Zhu is in the audience, and"},"33.02":{"start":"33.02","dur":"3.3","text":"we have three posters on this."},"36.32":{"start":"36.32","dur":"6.64","text":"So this is the Breast Phenotype Research Group."},"42.96":{"start":"42.96","dur":"7.19","text":"It includes various image analysis and genomic\nfolks, NCI, as well as radiologists from around"},"50.15":{"start":"50.15","dur":"2.86","text":"the country that have worked with these images."},"53.01":{"start":"53.01","dur":"5.06","text":"And our purpose is to demonstrate using this\ndata set, the role of quantitative radiomics"},"58.07":{"start":"58.07","dur":"5.75","text":"in characterizing the molecular subtypes of\nbreast cancer, and associating that with genomic"},"63.82":{"start":"63.82","dur":"1.68","text":"data."},"65.50":{"start":"65.5","dur":"6.08","text":"We come from a history of research and computer-aided\ndiagnosis, where we\u2019ve used computer vision"},"71.58":{"start":"71.58","dur":"6.84","text":"techniques to extract out the information,\nand then based on clinical information, create"},"78.42":{"start":"78.42","dur":"6.75","text":"the knowledge to aid in diagnosis or prognosis\nof the patient and now using it in data mining."},"85.17":{"start":"85.17","dur":"2.16","text":"A few definitions."},"87.33":{"start":"87.33","dur":"5.86","text":"So radiomics is the high throughput conversion\nof images to minable data and radiogenomics,"},"93.19":{"start":"93.19","dur":"6.08","text":"or imaging genomics, is the association of\nthese features with genomics and other omics"},"99.27":{"start":"99.27","dur":"1","text":"data."},"100.27":{"start":"100.27","dur":"4.87","text":"So we\u2019re interested in asking questions\nabout the relationships seen in these clinical"},"105.14":{"start":"105.14","dur":"5.339","text":"medical images that are obtained routinely\nin practice, and their relationship with the"},"110.48":{"start":"110.479","dur":"2.021","text":"biology of cancer."},"112.50":{"start":"112.5","dur":"5.78","text":"We want to know which correlate, which complement,\nto potential lead to personalized screening"},"118.28":{"start":"118.28","dur":"2.28","text":"and personalized treatment."},"120.56":{"start":"120.56","dur":"6.72","text":"Most of you are in this area, and what we\u2019re\ninterested in, is incorporating this radiomics"},"127.28":{"start":"127.28","dur":"5.95","text":"part into the association and predictive model\ndevelopment."},"133.23":{"start":"133.23","dur":"4.421","text":"So this is our computerated diagnostic workstation\n[spelled phonetically], which is now our high"},"137.65":{"start":"137.651","dur":"2.899","text":"throughput MRI phenotyping system."},"140.55":{"start":"140.55","dur":"4.65","text":"Once the lesion is identified, the computer\nautomatically segments the lesion and pulls"},"145.20":{"start":"145.2","dur":"3.36","text":"out the various phenotypes."},"148.56":{"start":"148.56","dur":"2.08","text":"This is our data set."},"150.64":{"start":"150.64","dur":"7.42","text":"We work with the breast cancer cases from\nthe TCGA where clinical, histopathology, and"},"158.06":{"start":"158.06","dur":"5.75","text":"genomic data is downloaded using TCGA assembler,\nand molecular subtyping and risk recurrent"},"163.81":{"start":"163.81","dur":"4.179","text":"values were obtained from the Perou Lab at\nUNC."},"167.99":{"start":"167.989","dur":"6.231","text":"In this data set, there were only at the time\n91 cases that had imaging data."},"174.22":{"start":"174.22","dur":"2.37","text":"More are being collected."},"176.59":{"start":"176.59","dur":"2.789","text":"This is the distribution of those cases."},"179.38":{"start":"179.379","dur":"11.301","text":"Many are ER positive, PR positive, HER2 negative,\nand most are not triple negative."},"190.68":{"start":"190.68","dur":"6.139","text":"Most of them are Luminal A in the cancer molecular\nsubtype."},"196.82":{"start":"196.819","dur":"5.631","text":"And from these cases, we downloaded the breast\nMRI images and do the computational image"},"202.45":{"start":"202.45","dur":"2.759","text":"analysis phenotyping."},"205.21":{"start":"205.209","dur":"3.611","text":"Let me take a few moments to talk about breast\nMRI."},"208.82":{"start":"208.82","dur":"4.639","text":"Since tumors have the increased blood vessels\nand different microvascular density and vessel"},"213.46":{"start":"213.459","dur":"7.091","text":"permeability, we can look at the -- we can\nobtain MR images over time after injection"},"220.55":{"start":"220.55","dur":"2.409","text":"of a gadolinium contrast agent."},"222.96":{"start":"222.959","dur":"5.941","text":"So here we have a pre-contrast, a post-contrast\nand a subtraction, and you can see the tumor"},"228.90":{"start":"228.9","dur":"1.449","text":"is highlighted."},"230.35":{"start":"230.349","dur":"6.67","text":"We do this analysis in 4-D. That is, as we\ninject the contrast, we continue to image,"},"237.02":{"start":"237.019","dur":"5.44","text":"and we can obtain data in 3-D, so 4-D analysis."},"242.46":{"start":"242.459","dur":"5.351","text":"Most of the figures I\u2019m showing will be\na slice, but the analysis is done in 4-D."},"247.81":{"start":"247.81","dur":"3.11","text":"What we\u2019re interested in is looking at this\nuptake."},"250.92":{"start":"250.92","dur":"6.76","text":"So if it&#39;s high, uptake is quick and the washout\nis quick, chances are it\u2019s a cancerous lesion,"},"257.68":{"start":"257.68","dur":"2.41","text":"whereas other ones might be more persistent\nor plateau."},"260.09":{"start":"260.09","dur":"4.5","text":"It doesn\u2019t me they\u2019re not cancerous, but\nlikely not."},"264.59":{"start":"264.59","dur":"3.13","text":"The first step we do is to segment the tumor."},"267.72":{"start":"267.72","dur":"4.83","text":"Here examples are two cases and then read\nare the computer-segmented lesions [spelled"},"272.55":{"start":"272.55","dur":"1","text":"phonetically]."},"273.55":{"start":"273.55","dur":"3.22","text":"To better give you an idea of what this is,\nthis is a 3-D breast MRI."},"276.77":{"start":"276.77","dur":"4.59","text":"This is a clinically-obtained breast image."},"281.36":{"start":"281.36","dur":"3.27","text":"You can see right here is the tumor."},"284.63":{"start":"284.63","dur":"4.53","text":"And, so this is -- we indicate that tumor\nto the computer."},"289.16":{"start":"289.16","dur":"2.67","text":"The computer then does the segmentation."},"291.83":{"start":"291.83","dur":"5.04","text":"Within that segmented region, we are looking\nat characteristics of the tumor, both around"},"296.87":{"start":"296.87","dur":"4.87","text":"the margin, as well as distribution of uptake\nwithin the tumor."},"301.74":{"start":"301.74","dur":"2.82","text":"And we&#39;re calling this a virtual biopsy."},"304.56":{"start":"304.56","dur":"4.82","text":"Note here, we can analyze the entire tumor,\nrelatively real biopsy."},"309.38":{"start":"309.38","dur":"5.03","text":"We\u2019re doing it non-invasively so we can\nrepeat it over time, and we can spatially"},"314.41":{"start":"314.41","dur":"6.45","text":"know where we\u2019re looking at as opposed to\na surgical biopsy where you\u2019re not quite"},"320.86":{"start":"320.86","dur":"1.141","text":"sure where the needle is going in."},"322.00":{"start":"322.001","dur":"5.899","text":"And so we hope to correlate between the two."},"327.90":{"start":"327.9","dur":"4.45","text":"Once we have that lesion, we then can extract\nout multiple phenotypes."},"332.35":{"start":"332.35","dur":"6.36","text":"So, we can look at size, volume, maximum linear\nsize, surface area."},"338.71":{"start":"338.71","dur":"4.93","text":"We look at the shape of the tumor, the sphericity\nor how irregular the shape is."},"343.64":{"start":"343.64","dur":"5.7","text":"We look at the sharpness of the margin of\nthe tumor, and other features."},"349.34":{"start":"349.34","dur":"6.07","text":"And based on the uptake, because this is dynamically\nobtained contrast enhanced MRI, we look at"},"355.41":{"start":"355.41","dur":"4.41","text":"the enhancement heterogeneity and kinetics\nof the uptake and washout."},"359.82":{"start":"359.82","dur":"5.45","text":"For example here, this is a slice through\none of the tumors and at each of those voxels,"},"365.27":{"start":"365.27","dur":"3.47","text":"we can look at the uptake over time."},"368.74":{"start":"368.74","dur":"4.34","text":"And you see that there\u2019s curves on the right\nvery greatly, and that\u2019s the heterogeneity"},"373.08":{"start":"373.08","dur":"2.08","text":"of the uptake within the tumor."},"375.16":{"start":"375.16","dur":"4.74","text":"So what we do is we look at, at one point\nin time, how that differs."},"379.90":{"start":"379.9","dur":"4.56","text":"And we\u2019re interested in relating the heterogeneity\nthat we\u2019re seeing in the imaging, from the"},"384.46":{"start":"384.46","dur":"6.579","text":"angiogenesis, to the heterogeneity that you\nare seeing in analysis of the genomics at"},"391.04":{"start":"391.039","dur":"3.531","text":"different locations within the tumor."},"394.57":{"start":"394.57","dur":"5.21","text":"So we can look at the texture, and we do various\ncomputer-vision texture analysis methods."},"399.78":{"start":"399.78","dur":"4.06","text":"We look at the uptake and washout, and we\nlook at the variants of that."},"403.84":{"start":"403.84","dur":"7.32","text":"And those are given as our various phenotypes\nof our noninvasive virtual biopsy."},"411.16":{"start":"411.16","dur":"6.42","text":"So in the TCIA breast group, we\u2019re relating\nthese computer extracted phenotypes to various"},"417.58":{"start":"417.58","dur":"1.83","text":"tasks."},"419.41":{"start":"419.41","dur":"5.46","text":"For example, for clinical tumor status, here\nwe show the surface area extracted by the"},"424.87":{"start":"424.87","dur":"6.769","text":"computer relative to stage, and we see that\nit is predictive of breast cancer tumor stage."},"431.64":{"start":"431.639","dur":"5.991","text":"We can look at it relative to molecular classification\nin cancer subtype."},"437.63":{"start":"437.63","dur":"5.9","text":"For example, we have shown that on this limited\ndata set, that ER negative breast cancers"},"443.53":{"start":"443.53","dur":"5.09","text":"tended to have larger size, a more irregular\nshape, and were more heterogeneous in terms"},"448.62":{"start":"448.62","dur":"2.82","text":"of the contrast enhancements."},"451.44":{"start":"451.44","dur":"4.569","text":"For triple negative, they tended to have a\nmore irregular shape, and more heterogeneous"},"456.01":{"start":"456.009","dur":"2.78","text":"in terms of the contrast enhancement."},"458.79":{"start":"458.789","dur":"3.201","text":"What happened?"},"461.99":{"start":"461.99","dur":"1.59","text":"Oh."},"463.58":{"start":"463.58","dur":"1.6","text":"Okay."},"465.18":{"start":"465.18","dur":"4.739","text":"I\u2019m not sure what happened, but okay."},"469.92":{"start":"469.919","dur":"4.751","text":"We also compare this to the molecular subtype,\nand here we\u2019re showing that the enhancement"},"474.67":{"start":"474.67","dur":"5.69","text":"texture of the tumor heterogenic appears to\nbe predictive of molecular subtype."},"480.36":{"start":"480.36","dur":"6.559","text":"And here at the bottom we show normal like,\nLuminal A, Luminal B, HER2-enriched, and basal-like"},"486.92":{"start":"486.919","dur":"1.951","text":"breast cancers."},"488.87":{"start":"488.87","dur":"4.76","text":"And as you go across the graft, it gets, the\nprognosis is worse."},"493.63":{"start":"493.63","dur":"2.8","text":"And this was a statistical trend."},"496.43":{"start":"496.43","dur":"4.72","text":"Now, in our analyses, and we realize that\nthe tumor size is very important, so we try"},"501.15":{"start":"501.15","dur":"5.769","text":"to control for that, and we still see this\nenhancement texture of the tumor heterogeneity"},"506.92":{"start":"506.919","dur":"5.271","text":"being predicted by the molecular subtype as\nshown here, where the plot on the left are"},"512.19":{"start":"512.19","dur":"4.729","text":"for very small tumors and the one on the right\nis two centimeters to five centimeters."},"516.92":{"start":"516.919","dur":"5.55","text":"We\u2019ve also related these to the risk or\nrecurrence for multi-gene assays from Chuck"},"522.47":{"start":"522.469","dur":"2.16","text":"Crews&#39; lab at UNC."},"524.63":{"start":"524.629","dur":"3.63","text":"Here\u2019s an example of two cancers."},"528.26":{"start":"528.259","dur":"2.851","text":"The one on the left is one of a good prognostic\ncase."},"531.11":{"start":"531.11","dur":"3.12","text":"The one on the right is a poor prognostic\ncase."},"534.23":{"start":"534.23","dur":"7.969","text":"These were analyzed with the research OncotypeDX,\nMammaPrint, and the PAM50 test, as well as"},"542.20":{"start":"542.199","dur":"6.73","text":"our radiomics, looking at tumor size, tumor\nshape irregularity, and the heterogeneity"},"548.93":{"start":"548.929","dur":"1.361","text":"of the uptake."},"550.29":{"start":"550.29","dur":"6.989","text":"And I know you can\u2019t read this, but I put\nthis up only again to show that we are finding"},"557.28":{"start":"557.279","dur":"6.781","text":"statistically significant correlation, and\nthe same types of features are being shown"},"564.06":{"start":"564.06","dur":"6.61","text":"again; tumor size, irregularity and uptake\nheterogeneity."},"570.67":{"start":"570.67","dur":"3.169","text":"Okay."},"573.84":{"start":"573.839","dur":"6.571","text":"We can also present this in terms of ROC analysis\nin looking at good prognosis versus poor prognosis"},"580.41":{"start":"580.41","dur":"3.2","text":"for these various research gene assays."},"583.61":{"start":"583.61","dur":"5.86","text":"And the black curve here on the upper right\nof the ROC analysis is the performance of"},"589.47":{"start":"589.47","dur":"9.559","text":"these computer-extracted tumor signatures\nin terms of predicting poor and not-so-poor"},"599.03":{"start":"599.029","dur":"2.451","text":"prognostics."},"601.48":{"start":"601.48","dur":"5.13","text":"And then ultimately, we can relate these phenotypes\nto genomic pathways."},"606.61":{"start":"606.61","dur":"6.469","text":"One thing I want to point out is that while\nwe\u2019re pushing imaging to see as much as"},"613.08":{"start":"613.079","dur":"5.971","text":"we can, what we can see from just the imaging\nalone, it\u2019s not that we would just use imaging."},"619.05":{"start":"619.05","dur":"5.45","text":"Ultimately, we want to see if we can merge\nimaging with genomics and other features to"},"624.50":{"start":"624.5","dur":"4.069","text":"come up with a better prognostic signature."},"628.57":{"start":"628.569","dur":"8.27","text":"Also, we want to ultimately correlate our\nimaging signatures, our virtual biopsy signatures"},"636.84":{"start":"636.839","dur":"8.62","text":"with actual biopsies, so that we could non-invasively\nfollow a patient over time during therapy,"},"645.46":{"start":"645.459","dur":"5.211","text":"and also spatially correlate that information."},"650.67":{"start":"650.67","dur":"2.58","text":"So moving on to the genomic pathways."},"653.25":{"start":"653.25","dur":"8.25","text":"Here, the data was extracted from the TCGA\nusing the TCGA assembler software again, and"},"661.50":{"start":"661.5","dur":"5.16","text":"we used the imaging data from the MRIs."},"666.66":{"start":"666.66","dur":"5.889","text":"We looked at genetic pathways associated with\nthe radio phenotypes, regression analysis"},"672.55":{"start":"672.549","dur":"3.361","text":"was done, as was clustering analysis."},"675.91":{"start":"675.91","dur":"5.769","text":"So in the exploratory cluster analysis of\nthe MR phenotypes, significant associations"},"681.68":{"start":"681.679","dur":"4.91","text":"were found between these radiomic features\nand the clinical outcomes as shown earlier."},"686.59":{"start":"686.589","dur":"7.03","text":"And, however, this was done using the typical\ngenomic clustering methods, treating the MR"},"693.62":{"start":"693.619","dur":"3.071","text":"phenotype as another phenotype."},"696.69":{"start":"696.69","dur":"8.209","text":"The various associations were show with the\nMR phenotypes and various pathway transcriptional"},"704.90":{"start":"704.899","dur":"5.13","text":"activities, and I will list the posters where\nthis is shown in more detail at the end of"},"710.03":{"start":"710.029","dur":"1.691","text":"the talk."},"711.72":{"start":"711.72","dur":"7.849","text":"Here, red is high positive correlation and\ndark green is -- and light green is the high"},"719.57":{"start":"719.569","dur":"6.19","text":"negative associations."},"725.76":{"start":"725.759","dur":"6.06","text":"We also identified significant associations,\nand particularly the size phenotype, very"},"731.82":{"start":"731.819","dur":"4.76","text":"strong, related to various gene expressions\nof pathways."},"736.58":{"start":"736.579","dur":"6.26","text":"And this enhancement texture heterogeneity\nphenotypes were related again to the MiRNA"},"742.84":{"start":"742.839","dur":"1","text":"expression."},"743.84":{"start":"743.839","dur":"5.571","text":"So the same phenotypes, looking at them from\ndifferent ways, keep appearing."},"749.41":{"start":"749.41","dur":"5.929","text":"So in summary, computational quantitative\nMRI analysis shows promise as a means for"},"755.34":{"start":"755.339","dur":"5.631","text":"high throughput image based phenotyping and\nappears to predict a breast cancer molecular"},"760.97":{"start":"760.97","dur":"1.789","text":"subtypes."},"762.76":{"start":"762.759","dur":"5.971","text":"Radiomics of tumor size and enhancement heterogeneity\nappear as dominant phenotypes in classifying"},"768.73":{"start":"768.73","dur":"5.629","text":"these subtypes and risk a recurrence, and\nsignificant associations were identified between"},"774.36":{"start":"774.359","dur":"7.301","text":"the phenotypes and molecular features involved\nin multiple regulation layers."},"781.66":{"start":"781.66","dur":"7.01","text":"A main limitation is that there are only 91\nbreast MRI cases, even though there\u2019s 1,000"},"788.67":{"start":"788.67","dur":"1.349","text":"breast cancers in the TCGA."},"790.02":{"start":"790.019","dur":"6.88","text":"TCIA is collecting additional images, and\nwe\u2019re also organizing, outside of that,"},"796.90":{"start":"796.899","dur":"5.021","text":"a multi-institutional radio mixed network\nto collect cases."},"801.92":{"start":"801.92","dur":"6.06","text":"For example, at my institution, we\u2019ve collected\n800 breast cancer cases with MRI, and now"},"807.98":{"start":"807.98","dur":"5.89","text":"we\u2019re collecting the pathology and, if possible,\nthe genomics on them to validate these promising"},"813.87":{"start":"813.87","dur":"2.35","text":"features."},"816.22":{"start":"816.22","dur":"4.679","text":"Identification of radiomics of molecular subtypes\nof breast tumors is expected to allow for"},"820.90":{"start":"820.899","dur":"6.71","text":"these virtual biopsies to augment actual biopsies,\nand ongoing research involves relating and"},"827.61":{"start":"827.609","dur":"5.181","text":"merging the MR phenotypes with genomic data\nto development and improve predictive models."},"832.79":{"start":"832.79","dur":"3.339","text":"I\u2019d like to end with these questions."},"836.13":{"start":"836.129","dur":"5.471","text":"Is it possible to decide targeted therapy\nbased on imaging and genomics association"},"841.60":{"start":"841.6","dur":"1.69","text":"results?"},"843.29":{"start":"843.29","dur":"4.089","text":"Can imaging features inform important genomic\nfeatures?"},"847.38":{"start":"847.379","dur":"1","text":"Not in this work."},"848.38":{"start":"848.379","dur":"7.32","text":"In prior work that we\u2019ve done, in the association\nof future risk of breast cancer, we\u2019ve used"},"855.70":{"start":"855.699","dur":"9.19","text":"imaging and other genomic association results\nto direct the analysis as opposed to going"},"864.89":{"start":"864.889","dur":"3.93","text":"to GWAS to improve the statistics."},"868.82":{"start":"868.819","dur":"4.531","text":"Can integration of imaging in genomic features\nlead to a higher power in prediction, and"},"873.35":{"start":"873.35","dur":"7.139","text":"can imaging serve as a virtual biopsy be noninvasive,\ncovering the complete tumor, and being repeatable?"},"880.49":{"start":"880.489","dur":"7.02","text":"I\u2019d like to thank you and reference a workshop\nof the TCIA here on imaging resources for"},"887.51":{"start":"887.509","dur":"1","text":"the TCGA."},"888.51":{"start":"888.509","dur":"5.76","text":"That\u2019s today at 4:00 and 5:00 in posters\n91, 79, and 105."},"894.27":{"start":"894.269","dur":"3.11","text":"Thank you."},"897.38":{"start":"897.379","dur":"3.11","text":"[applause]"},"900.49":{"start":"900.489","dur":"8.13","text":"Male Speaker:\nThank you for excellent talk."},"908.62":{"start":"908.619","dur":"2.481","text":"And just two notes."},"911.10":{"start":"911.1","dur":"3.769","text":"One, radiogenomics right now is used by two\ngroups."},"914.87":{"start":"914.869","dur":"2.22","text":"The affect of radiation on genome --"},"917.09":{"start":"917.089","dur":"1.65","text":"Maryellen Giger:\nYes."},"918.74":{"start":"918.739","dur":"4.09","text":"Male Speaker:\n-- and genes and also the radiomic and genomic"},"922.83":{"start":"922.829","dur":"1","text":"combination."},"923.83":{"start":"923.829","dur":"7.32","text":"It needs just somehow clarification when we\nare using one term and we are calling it actually"},"931.15":{"start":"931.149","dur":"1","text":"one term."},"932.15":{"start":"932.149","dur":"2.271","text":"It\u2019s better to be more precise."},"934.42":{"start":"934.42","dur":"3.159","text":"I totally agree with your usage."},"937.58":{"start":"937.579","dur":"7.531","text":"In my opinion, radiogenomic more implies radiomic\nand genomic, but there are other opinion also"},"945.11":{"start":"945.11","dur":"1.289","text":"out there."},"946.40":{"start":"946.399","dur":"6.761","text":"And the second one is that radiomic in particular\nis able to capture the heterogeneity in the"},"953.16":{"start":"953.16","dur":"9.019","text":"tumor, and what we have at the moment, at\nleast, is just one snapshot of the genomic."},"962.18":{"start":"962.179","dur":"7.861","text":"Many times, when you are going to integrate\nthe heterogeneity captured by radiomic, just"},"970.04":{"start":"970.04","dur":"6.989","text":"one sample in the genomic sequencing, there\nwill be a mismatch and how you\u2019re going"},"977.03":{"start":"977.029","dur":"1","text":"to handle that."},"978.03":{"start":"978.029","dur":"2.701","text":"We don\u2019t have that ability at the moment\nat least."},"980.73":{"start":"980.73","dur":"1","text":"Maryellen Giger:\nOkay."},"981.73":{"start":"981.73","dur":"2.77","text":"Well, first off, I completely agree with you\non both points."},"984.50":{"start":"984.5","dur":"5.669","text":"One, I actually -- the radiomics, I agree\nwith that term."},"990.17":{"start":"990.169","dur":"4.57","text":"Radiogenomics, actually I prefer saying imaging\ngenomics because of the confusion, because"},"994.74":{"start":"994.739","dur":"5.09","text":"there are other folks where radiogenomics\nis looking at more of the changes based on"},"999.83":{"start":"999.829","dur":"1.331","text":"the radiation."},"1001.16":{"start":"1001.16","dur":"1.769","text":"So I completely agree."},"1002.93":{"start":"1002.929","dur":"4.301","text":"That name is sticking, but I will go back\nto pushing for imaging genomics."},"1007.23":{"start":"1007.23","dur":"6.159","text":"I also agree on your second point, and that\u2019s\nexactly why we want to take the imaging data,"},"1013.39":{"start":"1013.389","dur":"3.281","text":"where we can get complete coverage of the\ntumor."},"1016.67":{"start":"1016.67","dur":"6.5","text":"We realize that the genomics is based on maybe\none or two biopsies only, and that the genomic"},"1023.17":{"start":"1023.17","dur":"6.229","text":"heterogeneity is slightly different to the\nimaging heterogeneity that we\u2019re seeing,"},"1029.40":{"start":"1029.399","dur":"1.461","text":"but we need to relay them."},"1030.86":{"start":"1030.86","dur":"8.449","text":"So I have a slide -- I didn&#39;t put it in -- it\u2019s\nmy proposal, which I\u2019m pressing for, is"},"1039.31":{"start":"1039.309","dur":"5.661","text":"that we can do whole mount pathology."},"1044.97":{"start":"1044.97","dur":"4.949","text":"So instead of the small slide when there\u2019s\na mastectomy, we have a slide this big, and"},"1049.92":{"start":"1049.919","dur":"5.63","text":"it\u2019s kind of like a slice through the breast\nwhere you have the parenchyma and the tumor."},"1055.55":{"start":"1055.549","dur":"6.681","text":"And what we want to do is spatially orientate\nit, multi-omics relationships, because at"},"1062.23":{"start":"1062.23","dur":"5.559","text":"that point, yes, we can capture the entire\ntumor with imaging."},"1067.79":{"start":"1067.789","dur":"1.281","text":"Right now you can\u2019t do that."},"1069.07":{"start":"1069.07","dur":"2.76","text":"It\u2019s a partial picture with the genomics."},"1071.83":{"start":"1071.83","dur":"5.829","text":"But with a whole mount comparison and what\nwe will do is then, you could do complete"},"1077.66":{"start":"1077.659","dur":"4.781","text":"genomics through the tumor, and you can them\nspatially relate it to the MRI."},"1082.44":{"start":"1082.44","dur":"2.9","text":"In fact, I almost put that slide in."},"1085.34":{"start":"1085.34","dur":"4.99","text":"I did not ask him to ask these two questions,\nbut those are the perfect two questions I"},"1090.33":{"start":"1090.33","dur":"1.74","text":"would want someone to ask me."},"1092.07":{"start":"1092.07","dur":"5.71","text":"And that will help answer that problem of\n-- because once we understand for the cases"},"1097.78":{"start":"1097.78","dur":"5.83","text":"that we do get the entire breast, not only\ncan we look at the tumor, we can do virtual"},"1103.61":{"start":"1103.61","dur":"2.58","text":"biopsy on the stroma around it."},"1106.19":{"start":"1106.19","dur":"2.38","text":"And that\u2019s very important."},"1108.57":{"start":"1108.57","dur":"6.01","text":"So we\u2019re setting up this whole mount pathology\nlab to precisely do that."},"1114.58":{"start":"1114.58","dur":"4.959","text":"And once we can understand that relationship,\nthen for cases where we don\u2019t get the complete"},"1119.54":{"start":"1119.539","dur":"4.671","text":"tumor, we can hopefully rely on what we\u2019re\nseeing in the images, and then do it repeatedly"},"1124.21":{"start":"1124.21","dur":"1.57","text":"over time during treatment."},"1125.78":{"start":"1125.78","dur":"5.05","text":"Male Speaker:\nI just wanted to add that right now, by the"},"1130.83":{"start":"1130.83","dur":"7.27","text":"facilities, by image-guided biopsies and intervention,\nwe have the ability to have the tissue sample"},"1138.10":{"start":"1138.1","dur":"4.63","text":"from the exact location which we know in the\nimage."},"1142.73":{"start":"1142.73","dur":"6.01","text":"And if you just want to correlate the texture\nor whatever of that special location to the"},"1148.74":{"start":"1148.74","dur":"7.08","text":"genes, it\u2019s possible, and interventional\noncology can really provide a very good platform"},"1155.82":{"start":"1155.82","dur":"1.489","text":"for this endeavor."},"1157.31":{"start":"1157.309","dur":"1","text":"Thank you."},"1158.31":{"start":"1158.309","dur":"1.881","text":"Maryellen Giger:\nYes, we&#39;ve done it with the breast cancer"},"1160.19":{"start":"1160.19","dur":"2.829","text":"and also with the prostate cancer."},"1163.02":{"start":"1163.019","dur":"1.52","text":"So thank you for that."},"1164.54":{"start":"1164.539","dur":"2.081","text":"Male Speaker:\nThank you."},"1166.62":{"start":"1166.62","dur":"3.779","text":"Maryellen Giger:\nSo, if you have images of some of your cases"},"1170.40":{"start":"1170.399","dur":"4.091","text":"and you\u2019d like to collaborate, please let\nme know."},"1174.49":{"start":"1174.49","dur":"2.17","text":"[applause]"},"1176.66":{"start":"1176.66","dur":"5.83","text":"Katherine Hoadley:\nSo thank you to all the speakers from this"},"1182.49":{"start":"1182.49","dur":"1","text":"morning\u2019s session."},"1183.49":{"start":"1183.49","dur":"1.1","text":"I do have home request."},"1184.59":{"start":"1184.59","dur":"4.959","text":"If you are a speaker in the afternoon session,\nif you can please come up here, right after"},"1189.55":{"start":"1189.549","dur":"2.881","text":"I finish speaking, we\u2019d like to talk to\nyou for a second."},"1192.43":{"start":"1192.43","dur":"2.57","text":"Also, we will have lunch now on your own."},"1195.00":{"start":"1195","dur":"4.44","text":"Posters start at 1:00, and we\u2019ll start back\npromptly at 2:00 with session two."},"1199.44":{"start":"1199.44","dur":"1","text":"Thank you, everybody."},"1200.44":{"start":"1200.44","dur":"0.003","text":"[end of transcript]"}}